Skip to content

    Strata Critical Medical (SRTA) stock price & financials

    View SRTA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+30.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $36.06M
    -$8.70M
    $35.95M
    $45.11M
    $49.30M
    +36.7%
    $66.79M
    $67.38M
    +87.4%
    $72.51M
    +60.7%
    Strengthening
    Operating Profit
    -$7.09M
    $6.58M
    -$5.68M
    -$4.64M
    -$5.62M
    +20.7%
    -$6.41M
    -197.3%
    -$2.97M
    +47.7%
    -$5.41M
    -16.5%
    Weakening
    Net Profit
    -$1.95M
    -$9.79M
    -$3.49M
    -$3.74M
    $57.42M
    -$8.83M
    +9.8%
    $2.15M
    -$10.52M
    -181.0%
    Weakening
    EPS
    $-0.03
    $-0.04
    $-0.05
    $0.70
    $0.03
    $-0.12
    -140.0%
    Weakening
    Other Income
    $1.47M
    -$1.53M
    $4.07M
    $1.23M
    -$4.04M
    -375.4%
    $1.02M
    $5.38M
    +32.0%
    -$5.11M
    -514.6%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$5.63M
    $5.06M
    -$1.61M
    -$3.41M
    -$9.66M
    -71.6%
    -$5.39M
    -206.5%
    $2.40M
    -$10.52M
    -208.5%
    Weakening
    MarginsOPM
    -19.7%
    -75.6%
    -15.8%
    -10.3%
    -11.4%
    +42.0%
    -9.6%
    +87.3%
    -4.4%
    +72.1%
    -7.5%
    +27.5%
    Strengthening
    Tax
    0.0%
    0.6%
    0.0%
    0.0%
    0.0%
    0.0%
    -100.0%
    0.0%
    0.0%
    Weakening
    ReturnsROIC
    1.3%
    6.4%
    2.3%
    2.4%
    -37.3%
    -3038.4%
    5.7%
    -9.8%
    -1.4%
    -161.7%
    6.8%
    +181.0%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$1.31M$12.16M$10.22M$6.95M$41.34M$27.87M$18.38M$30.97M$16.32M
    Short-Term Investments
    Total Current Assets$1.43M$14.38M$896.1K$314.45M$218.13M$206.26M$160.74M$126.19M$121.01M
    Net PP&E$2.50M$2.61M$19.73M$26.38M$31.30M$39.55M$44.64M
    Goodwill$0$13.27M$39.45M$13.33M$15.54M$88.21M$106.95M
    Intangibles$533.0K$12.64M$46.37M$20.52M$7.96M$47.50M$60.01M
    Total Assets$277.69M$17.71M$277.84M$343.39M$325.02M$294.94M$256.68M$325.47M$332.70M
    LiabilitiesTotal Current Liabilities$371.3K$6.34M$390.8K$9.53M$26.61M$35.49M$22.73M$19.79M$45.78M
    Short-Term Debt
    Long-Term Debt$0
    Long-Term Leases$291.0K$222.0K$14.97M$19.74M$2.34M$2.65M$3.20M
    Total Liabilities$26.11M$6.63M$46.78M$52.16M$50.54M$60.64M$34.74M$46.40M$53.38M
    EquityCommon Stock & APIC$3.0K$7.0K$7.0K$7.0K$7.0K$7.0K$7.0K
    Retained Earnings$2.33M-$37.14M-$18.19M-$77.19M-$103.68M-$159.75M-$186.90M-$145.55M-$153.91M
    Total Equity$5.00M$11.08M$10.00M$291.23M$274.49M$234.30M$221.94M$279.07M$279.32M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$10.30M-$10.82M-$794.5K-$15.62M-$37.13M-$32.35M-$2.52M-$48.91M-$36.03M
    Cash from Investing-$1.05M-$377.0K$334.9K-$321.34M$79.34M$17.09M-$1.02M$69.75M$1.51M
    Cash from Financing$116.0K$1.18M$332.26M-$1.08M-$76.0K-$5.76M-$8.91M-$8.60M
    SummaryCapital Expenditure-$604.0K-$377.0K-$297.0K-$730.0K-$2.11M-$30.86M-$9.60M-$12.41M
    Free Cash Flow-$10.91M-$11.20M-$15.91M-$37.86M-$34.46M-$33.38M-$58.51M-$48.45M
    FCF Margin-35.0%-47.8%-31.5%-25.9%-15.3%-22.7%-29.7%-18.9%

    Ratios